Navigation Links
MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
Date:7/14/2008

in MAP0004 is dihydroergotamine (DHE), which has a long history of use as a safe and effective migraine treatment. Many headache specialists consider DHE administered by injection to be the standard of care in treating chronic migraine and debilitating migraines that last more than 72 hours. MAP Pharmaceuticals is seeking to expand the use of this compound to treat migraines early, non-invasively and with a fast onset of action.

MAP Pharmaceuticals is initiating the first Phase 3 trial of its MAP0004 product candidate pursuant to a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration. The SPA is intended to provide assurance that if pre-specified trial results are achieved, they may serve as the primary basis for an efficacy claim in support of a new drug application. In general, these assessments are considered binding on the FDA as well as the sponsor unless public health concerns unrecognized at the time the SPA is entered into become evident or other new scientific concerns regarding product safety or efficacy arise.

About Migraine

Migraine is a common, debilitating neurological disease affecting approximately 30 million people in the United States. It presents with recurrent attacks of headaches, nausea, vomiting and sensitivity to light and sound. Most migraines last between four and 24 hours, but some last as long as three days. On average, migraine sufferers experience 1.5 migraine attacks monthly, although 25 percent of them experience one or more attacks weekly.

In published studies, migraine sufferers often cite faster onset of pain relief and lower incidence of migraine recurrence as two key therapeutic attributes they would like from their medication. Currently approved drugs for the treatment of an acute migraine attack do not fully meet the needs of all patients due to the slow onset of action, short duration of effect, inconsistent response, unacceptable side effect profiles, or propensity to increa
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has ... - Global Industry Analysis, Size, Share, Growth, Trends And ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... on patients in order to treat dental impairments, for ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... , January 15, 2014 BreedIT Corp ... exclusive worldwide distributor of highly sophisticated agro-breeding solutions for ... 7, 2014, the Company,s board of directors appointed chemistry ... as its new member of the board. ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... Ill., Nov. 16, 2010 In response to an ... a way to facilitate the sharing and exchanging of ... of Pharmacy® (NABP®) will be developing an interconnected communications ... be operational in nine months, will be made accessible ...
... Reportlinker.com announces that a new market research ... Analgesics Industry http://www.reportlinker.com/p098419/Global-Analgesics-Industry.html ... markets for Analgesics in US$ Million by the ... Others (includes combination drugs)), and External Analgesics. The ...
Cached Medicine Technology:NABP Developing System to Link Prescription Monitoring Programs Across States to Facilitate Data Exchange 2Reportlinker Adds Global Analgesics Industry 2Reportlinker Adds Global Analgesics Industry 3Reportlinker Adds Global Analgesics Industry 4Reportlinker Adds Global Analgesics Industry 5Reportlinker Adds Global Analgesics Industry 6Reportlinker Adds Global Analgesics Industry 7Reportlinker Adds Global Analgesics Industry 8Reportlinker Adds Global Analgesics Industry 9Reportlinker Adds Global Analgesics Industry 10Reportlinker Adds Global Analgesics Industry 11Reportlinker Adds Global Analgesics Industry 12Reportlinker Adds Global Analgesics Industry 13Reportlinker Adds Global Analgesics Industry 14Reportlinker Adds Global Analgesics Industry 15Reportlinker Adds Global Analgesics Industry 16Reportlinker Adds Global Analgesics Industry 17Reportlinker Adds Global Analgesics Industry 18Reportlinker Adds Global Analgesics Industry 19Reportlinker Adds Global Analgesics Industry 20Reportlinker Adds Global Analgesics Industry 21
(Date:7/11/2014)... 11, 2014 On Tuesday, July 9, ... Annandale, VA office joined CBS affiliate WUSA’s Andrea ... educate the audience about the number of ways Shady ... motherhood possible for women after they undergo ... treat patients in the developing field known as oncofertility ...
(Date:7/11/2014)... Plasma resource reserves and control are crucial ... closure of 16 plasma collection stations in Guizhou in ... market, the total plasma volume in China blood products ... lot release volume declined by 7% from a year ... of new plasma stations and production break of some ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Even the hot ... Godley Elementary School . The school had ... playground equipment from APCPLAY, but recently asked for ... exposure. , Godley Elementary School chose a Rectangular ... and shelter for children on their playground. The shade ...
(Date:7/11/2014)... 2014 Based in Pearland, Prime Urgent ... of Brazoria County and surrounding counties. Recently, it improved ... now accessible from Northbound Highway 288 and Feeder Road. ... patients can get low-cost urgent care of high quality. ... finding places that can match the quality service level ...
(Date:7/10/2014)... Fatigue, lack of safety equipment and ... accidents in the workplace, according to a series ... safety issues that contribute to the alarming workplace ... the job annually, according to the International Labor ... workplace accidents." , Safety Issue: "Extended Work Hours ...
Breaking Medicine News(10 mins):Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4Health News:Cool Fun Under the Texas Sun: Godley Elementary School Purchases Shade Structure from APCPLAY© 2Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 3
... Edward R. Korman ordered the FDA to make the ... a physician,s visit or prescription and without parental consent. ... making the drug available to girls and women regardless ... Chris Gacek, Family Research Council , s Senior Fellow ...
... scheduled at 5:00 PM Eastern Time today Corporate Developments ... new drug application (NDA) to the U.S. Food ... a July 30, 2009 Prescription Drug User Fee Act ... NDA- January 2009: Completed merger with Novacea, Inc. ...
... Educational Campaign to Raise Awareness of Breast Cancer for Young ... and Living Beyond Breast Cancer applaud Representative Debbie Wasserman Schultz ... facing young women under the age of 40. The "Breast ... equires L earning Y oung Act of 2009," ...
... tightest control of risk factors, researchers report , , MONDAY, ... the major risk factors for heart disease seems to ... study shows. , And so the current guidelines for ... might need to be tightened even further, said Dr. ...
... 23 Four Miami-area residents pleaded guilty today in ... HIV infusion clinics, Acting Assistant Attorney General Rita M. ... Alexander Acosta of the Southern District of Florida announced ... Gonzalo Nodarse, 38; and Alexis Carrazana, 41; all pleaded ...
... Based on its recent analysis of the medical ... the 2009 North American Frost & Sullivan Product Innovation ... slice and iCT SP 128 slice computed tomography (CT) ... leading edge technology; they are also part of a ...
Cached Medicine News:Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 3Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 4Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 5Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 6Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 7Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 8Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 9Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 10Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 11Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 12Health News:Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultz's 'The Early Act' 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 2Health News:Lowest Blood Pressure, Cholesterol Levels the Best 3Health News:Two Doctors and Two Medical Assistants Plead Guilty in $10 Million Medicare Fraud Scheme 2Health News:Two Doctors and Two Medical Assistants Plead Guilty in $10 Million Medicare Fraud Scheme 3Health News:Frost & Sullivan Awards Philips Healthcare for Brilliance iCT 256 Slice and iCT SP 128 Slice CT Systems 2Health News:Frost & Sullivan Awards Philips Healthcare for Brilliance iCT 256 Slice and iCT SP 128 Slice CT Systems 3Health News:Frost & Sullivan Awards Philips Healthcare for Brilliance iCT 256 Slice and iCT SP 128 Slice CT Systems 4Health News:Frost & Sullivan Awards Philips Healthcare for Brilliance iCT 256 Slice and iCT SP 128 Slice CT Systems 5
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Auto refractometer....
... objective automatic refractor designed for those that ... are performed with an electronic joystick. It ... 1 degree of axis). The AR-600 fogs ... and maintains it throughout the measurement process. ...
... laser is mounted on Haag Streit slit-lamp. ... 0.2 and 2.0 mJ. The spot size ... microns. Knobs for laser energy and aiming ... laser head. The laser system complies with ...
Medicine Products: